Aubrey Elizabeth Klaich

M.D. | Neurology


  1201 N 175th St, Shoreline
     Washington, 98133-5064
  206-401-3175    206-401-3201 Maps & Directions
Aubrey Elizabeth Klaich is a Shoreline, Washington based neurologist who is specialized in Neurology. Her current practice location is 1201 N 175th St, Shoreline. Patients can reach her at 206-401-3175 or can fax her at 206-401-3201. Aubrey Elizabeth Klaich is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1578946307.
Aubrey Elizabeth Klaich specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Aubrey Elizabeth Klaich speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Aubrey Elizabeth Klaich
Specialization: Neurology
Gender:Female
Credentials: M.D.
Practice Address:1201 N 175th St, Shoreline,
Washington, 98133-5064
Phone:206-401-3175
Fax:206-401-3201
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1578946307
NPI Enumeration Date: 29 Jun, 2015
NPI Last Update On: 09 Sep, 2020

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Aubrey Elizabeth Klaich
Po Box 5127,
Everett, Washington
Zip: 98206-5127
Phone Number: 425-401-3175
Fax Number: 206-401-3201
Patients can reach Aubrey Elizabeth Klaich at 1201 N 175th St, Shoreline, Washington or can call to book an appointment on 206-401-3175.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.